Dextera Surgical Inc (NASDAQ:DXTR) traded down 35.7% on Wednesday . The stock traded as low as $0.08 and last traded at $0.09. 16,759,100 shares were traded during trading, an increase of 367% from the average session volume of 3,585,784 shares. The stock had previously closed at $0.14.
Several equities research analysts have recently weighed in on the company. Zacks Investment Research upgraded Dextera Surgical from a “sell” rating to a “hold” rating in a research report on Tuesday. Ladenburg Thalmann Financial Services assumed coverage on Dextera Surgical in a research report on Wednesday, August 16th. They set a “buy” rating and a $0.80 price target on the stock.
Dextera Surgical (NASDAQ:DXTR) last announced its quarterly earnings results on Thursday, November 9th. The medical instruments supplier reported ($0.09) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.07) by ($0.02). The firm had revenue of $0.69 million during the quarter, compared to analysts’ expectations of $0.62 million. sell-side analysts forecast that Dextera Surgical Inc will post -0.25 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: This report was originally reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this report on another publication, it was illegally copied and reposted in violation of United States & international trademark & copyright laws. The legal version of this report can be viewed at https://sportsperspectives.com/2017/12/13/dextera-surgical-dxtr-trading-down-35-7.html.
Dextera Surgical Company Profile
Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.
Receive News & Ratings for Dextera Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical and related companies with MarketBeat.com's FREE daily email newsletter.